MILATUZUMAB

UNII:	2OP4E0GC6V
Formula:
Preferred Substance Name:	MILATUZUMAB

899796-83-9
HLL1
IMMU-115
IMMUNOGLOBULIN G1, ANTI-(HUMAN CLASS II ANTIGEN INVARIANT CHAIN) (HUMAN- MOUSE MONOCLONAL HLL1 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL HLL1 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(HUMAN CLASS II ANTIGEN INVARIANT CHAIN) (HUMAN- MOUSE MONOCLONAL HLL1 HEAVY CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL HLL1 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(HUMAN CLASS II ANTIGEN INVARIANT CHAIN) (HUMAN-MOUSE MONOCLONAL HLL1 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL HLL1 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(HUMAN CLASS II ANTIGEN INVARIANT CHAIN) (HUMAN-MOUSE MONOCLONAL HLL1 HEAVY CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL HLL1 .KAPPA.-CHAIN, DIMER
MILATUZUMAB [INN]
MILATUZUMAB [MART.]
MILATUZUMAB [USAN]
MILATUZUMAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

MILATUZUMAB

Synonyms and Mappings

Resources